Purchase Order AG3A94P160035
- Not listed
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc. was awarded a purchase order valued at $12,587.48 for maintenance renewal services on Illumina sequencing equipment. The contract, issued on December 12, 2019, with an ultimate completion date of December 15, 2020, represents a firm fixed-price agreement with no set-aside designation. The work will be performed in Athens, Georgia, and is funded through a civilian federal agency's Southeast Area office. As a specialized biotechnology company headquartered in San Diego,...
- The U.S. government awarded a delivery order valued at $11,487.12 to Illumina, Inc. for two preventative maintenance visits servicing MiSeq genetic sequencers at a facility in Athens, Georgia. The contract, awarded July 2, 2025, with an ultimate completion date of October 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The funding agency is a civilian entity within the Southeast Area, reflecting Illumina's established role as a critical supplier of...
- Illumina, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $15,965.00 for maintenance services on comprehensive MiSeq equipment. The contract was awarded on November 9, 2015, with an ultimate completion date of September 9, 2019, and will be performed in Athens, Georgia. This maintenance agreement supports a civilian federal agency within the Southeast Area region. No set-aside designation was utilized for this award, reflecting Illumina's specialized...
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- The U.S. government awarded a firm fixed-price maintenance agreement to Illumina, Inc. for support of MiSeq laboratory equipment, with a ceiling value of $907,522.59. The contract, awarded by the Office of Administrative Services Procurement Management Branch on July 5, 2019, does not utilize a set-aside designation and reflects the government's recognition of Illumina's specialized capabilities in genomic sequencing technology. The work is to be performed in Athens, Georgia, with an ultimate...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $24,830.22 by a civilian federal agency within the Southeast Area on September 15, 2020. This firm fixed-price contract, with an ultimate completion date of October 30, 2020, required delivery of Illumina's sequencing products or services to Athens, Georgia. The contract was issued without set-aside designation, consistent with...
- Illumina, Inc. has been awarded an Annual Service Maintenance Agreement valued at $16,684.00 by the Office of Research and Development, a civilian federal agency. This firm fixed-price purchase order, issued on February 25, 2026, will be performed in San Diego, California, with an ultimate completion date of March 1, 2027. The contract represents a maintenance service engagement typical of Illumina's broader federal portfolio, which encompasses support for the company's advanced genetic...
- This firm fixed-price purchase order was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, by the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The $54,925.69 contract is for ILLUMINA EQUIPMENT MAINTENANCE services with a completion date of December 21, 2025. Illumina has a history of providing sequencing instruments, reagents, and bioinformatics products to support genomic research and diagnostics...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
The U.S. General Services Administration's Office of Administrative Services Procurement Management Branch awarded a $50,596.30 firm fixed price purchase order to Illumina, Inc. on May 11, 2016, for Illumina maintenance services with an ultimate completion date of January 1, 2018. The contract, which carries no set-aside designation, will be performed in Athens, Georgia. Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, is providing critical maintenance services to support the government's genomic research and analysis capabilities. This award reflects the company's established role as a key supplier of advanced DNA and RNA sequencing instruments, reagents, and related support services to federal agencies. Illumina's expertise spans multiple sectors including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs. The maintenance services covered under this purchase order ensure continued operational capability of Illumina's sequencing platforms, which are essential to federal scientific research, healthcare diagnostics, and genomic analysis initiatives across civilian agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 2/21/17 | |
| Not listed | Not listed | $50.6k | 5/11/16 |